Company intelligence / Profile preview

General Catalyst

Cambridge, Massachusetts, USAgeneralcatalyst.com ↗

Ownership: Private
Employees: ~250
Development stage: Phase 3

Overview

General Catalyst is not a drug or device developer but one of the world’s largest venture capital firms. It invests in early-stage through growth-stage companies across technology sectors including healthcare/life sciences. Its Health Assurance practice focuses on transforming healthcare by investing in innovative startups that address major unmet needs using technology such as AI and digital platforms. The firm has backed numerous successful health tech/biotech companies but does not have its own clinical pipeline or results.

Industry: Investors

Drug pipeline

1 asset

furmonertinib

Phase 3

Indications: Non-small cell lung cancer

Partnerships

Partnerships with hospital systems via Health Assurance Transformation Company initiative (~15% of US hospital operations involved).Collaborations with global governments through GC Institute to shape public policy around transformative technologies.

Beyond the preview

Go deeper on General Catalyst.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on General Catalyst.

Explore the full profile